media – Page 612 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

One Drop Integrates With Fitbit to Deliver Enhanced Diabetes Management Data Insights

One Drop, a leading diabetes care management platform announced they are partnering with Fitbit to help people better manage their Diabetes. By working together, Fitbit and One Drop can help make it easier for people to see how physical activity can impact blood glucose levels and make more informed care management decisions. In addition, One Drop will build an App for Fitbit Ionic, bringing One Drop data to the wrist.
- Source: hitconsultant
- 504
- November 1, 2017
blood glucose levels diabetes Market Views SDK
Samsung Biologics reinforces biologic manufacturing and development partnership with MSD

Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the US and Canada, with the signing of a memorandum of understanding. The relationship has come into force to streamline process development and clinical material production for small biotech start-ups focusing on novel drugs.
- Source: pharmafile
- 426
- November 1, 2017
Merck Samsung Biologics
Scientists pinpoint genetic risk factors for asthma, hay fever and eczema

A major international study has pinpointed more than 100 genetic risk factors that explain why some people suffer from asthma, hay fever and eczema.
- Source: Medicalxpress
- 495
- November 1, 2017
asthma eczema genetic risk hay fever Researches
Merck sales slip, even as Keytruda gains ground

Keytruda (pembrolizumab) was the main bright spot for Merck as it weathered blows from the NotPetya cyber attack, new competition and pricing pressures in hepatitis C.
- Source: 4-traders
- 692
- October 31, 2017
hepatitis inhibitor keytruda Market Views Opdivo
Novartis Slams Down $3.9B for This French Cancer Biotech

Fresh off the heels of its CAR-T approval, Novartis expanded its oncological arsenal with a $3.9 billion acquisition of French cancer firm Advanced Accelerator Applications.
- Source: Biospace
- 802
- October 31, 2017
CAR–T GEP-NETs Market Views neuroendocrine tumors
WHO report signals urgent need for greater political commitment to end tuberculosis

Global efforts to combat tuberculosis (TB) have saved an estimated 53 million lives since 2000 and reduced the TB mortality rate by 37%, according to the Global TB Report 2017, released by WHO today.
- Source: who
- 597
- October 31, 2017
Market Views tuberculosis WHO
PTSD linked to changes in gut bacteria

An exploratory study has identified a link between gut bacteria and post-traumatic stress disorder that could bring us closer to fathoming the mechanisms of the complex condition.
- Source: medicalnewstoday
- 709
- October 31, 2017
gut bacteria post-traumatic PTSD Researches
CVS-Aetna deal won’t necessarily make drugs cheaper — and could even raise prices

CVS Health Corp.’s bid for Aetna Inc., which could be valued at more than $66 billion, would — if successful — combine two businesses that have traditionally been separate, health insurance and pharmacy-benefit management.
- Source: marketwatch
- 432
- October 31, 2017
Company Insight CVS drug pharmacy
Ddu Attended CPhI Worldwide in Germany, Gaining Attention from the Whole Industry

The International Pharmaceutical Networking Exhibition (CPhI Worldwide 2017), was held at Ludwig-Erhard-Anlage 1 in Messe, Frankfurt, Germany from the 24th to the 26th of October 2017. As the leading global pharmaceutical & medical device B2B online platform, Ddu attended the exhibition, gaining attention from the whole industry.
- Source: Ddu
- 1,596
- October 31, 2017
CPhI Worldwide 2017 Exhibitions & Activities
FDA Calls BioMarin’s Hemophilia A Drug a Breakthrough

BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted its valoctocogene roxaparvovec for Hemophilia A Breakthrough Therapy Designation.
- Source: biospace
- 806
- October 31, 2017
Clinical Trial FDA hemophilia A

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.